Michael D Ezekowitz
Overview
Explore the profile of Michael D Ezekowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
186
Citations
21176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Steinberg B, Holmes D, Pieper K, Allen L, Chan P, Ezekowitz M, et al.
Circ Arrhythm Electrophysiol
. 2020 Apr;
13(5):e007775.
PMID: 32298144
Background: Atrial fibrillation (AF) adversely impacts health-related quality of life (hrQoL). While some patients demonstrate improvements in hrQoL, the factors associated with large improvements in hrQoL are not well described....
22.
Ezekowitz M, Kurz D, Kent A
J Am Coll Cardiol
. 2020 Apr;
75(14):1686-1688.
PMID: 32273034
No abstract available.
23.
Kloosterman M, Oldgren J, Conen D, Wong J, Connolly S, Avezum A, et al.
Europace
. 2020 Mar;
22(6):870-877.
PMID: 32215649
Aims: Data on patient characteristics, prevalence, and outcomes of atrial fibrillation (AF) patients without traditional risk factors, often labelled 'lone AF', are sparse. Methods And Results: The RE-LY AF registry...
24.
Kirchhof P, Ezekowitz M, Purmah Y, Schiffer S, Meng I, Camm A, et al.
TH Open
. 2020 Jan;
4(1):e20-e32.
PMID: 31984306
This X-VeRT (eXplore the efficacy and safety of once-daily oral riVaroxaban for the prevention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion) substudy evaluated the effects...
25.
Inohara T, Holmes D, Pieper K, Blanco R, Allen L, Fonarow G, et al.
Heart
. 2020 Jan;
106(5):358-364.
PMID: 31911503
Objective: Non-vitamin K oral anticoagulants (NOACs) require dose adjustment for renal function. We sought to investigate change in renal function over time in patients with atrial fibrillation (AF) and whether...
26.
Loring Z, Shrader P, Allen L, Blanco R, Chan P, Ezekowitz M, et al.
Am Heart J
. 2019 Nov;
219:21-30.
PMID: 31710841
Background: Comorbidities are common in patients with atrial fibrillation (AF) and affect prognosis, yet are often undertreated. However, contemporary rates of use of guideline-directed therapies (GDT) for non-AF comorbidities and...
27.
Merino J, Lip G, Heidbuchel H, Cohen A, De Caterina R, de Groot J, et al.
Europace
. 2019 Aug;
21(11):1633-1638.
PMID: 31436835
Aims: ENSURE-AF (NCT02072434) was the largest prospective randomized clinical trial of anticoagulation for cardioversion in atrial fibrillation (AF), which also provides the largest prospective dataset for transoesophageal echocardiography (TOE) prior...
28.
Pokorney S, Holmes D, Thomas L, Fonarow G, Kowey P, Reiffel J, et al.
JAMA Cardiol
. 2019 Jul;
4(8):756-764.
PMID: 31268487
Importance: Bleeding and thrombotic events (eg, stroke and systemic embolism) are common in patients with atrial fibrillation (AF) taking warfarin sodium despite a well-established therapeutic range. Objective: To evaluate whether...
29.
Inohara T, Shrader P, Pieper K, Blanco R, Allen L, Fonarow G, et al.
Am Heart J
. 2019 May;
213:81-90.
PMID: 31129441
Background: Treatment patterns and outcomes of individuals with vascular disease who have new-onset atrial fibrillation (AF) are not well characterized. Methods: Among patients with new-onset AF, we analyzed treatment and...
30.
Holmes D, Piccini J, Allen L, Fonarow G, Gersh B, Kowey P, et al.
Circ Cardiovasc Qual Outcomes
. 2019 May;
12(5):e005358.
PMID: 31092022
Background The Atrial Fibrillation Effect on Quality-of-Life (AFEQT) questionnaire has recently been validated to measure the impact of atrial fibrillation on quality of life, but a clinically important difference in...